Twin-to-twin transfusion syndrome is a serious pregnancy complication that can affect identical twins who share one placenta. In simple terms, it means blood flows unevenly between the babies, so one may get too little blood and the other too much. Twin-to-twin transfusion syndrome usually develops during pregnancy and can cause rapid belly growth, tightness, or contractions for the pregnant person, while the babies may show poor growth, too much or too little amniotic fluid, and strain on the heart. Not everyone will have the same experience, but severe twin-to-twin transfusion syndrome can lead to pregnancy loss, early birth, or serious illness if it is not treated. Treatment often includes close ultrasound monitoring, laser treatment to seal the connecting blood vessels, or early delivery when needed, and early symptoms of twin-to-twin transfusion syndrome should be checked promptly.
How many people live with Twin-to-twin transfusion syndrome?
Because twin-to-twin transfusion syndrome happens only during pregnancy, it is usually estimated as affected babies each year rather than as a lifelong head count: based on the fairly steady worldwide rate of identical twin pregnancies, and on TTTS affecting about 10% to 15% of twin pregnancies where both babies share one placenta, roughly 60,000 to 100,000 babies worldwide are affected each year, although this is an estimate rather than a direct count (Pison et al., 2021; Society for Maternal-Fetal Medicine, 2024). Using the same method with US birth data suggests about 1,800 to 2,700 babies a year in the United States, again as an estimate rather than a direct count (CDC National Center for Health Statistics, 2023; Society for Maternal-Fetal Medicine, 2024).
Overview
Twin-to-twin transfusion syndromeSymptoms
Twin-to-twin transfusion syndrome often causes no symptoms at first and is usually found on ultrasound. Some pregnant people notice rapid belly growth, tightness, pain, contractions, or sudden weight gain. Reduced movement from one or both babies needs urgent care.
Outlook and prognosis
Twin-to-twin transfusion syndrome can become serious quickly, but outcomes are often much better when it is found early and treated in a fetal medicine center. Prognosis depends on timing, severity, and how both twins respond before birth.
Causes and risk factors
Twin-to-twin transfusion syndrome happens only in identical twins sharing one placenta. Risk is highest with monochorionic twins; it is not caused by anything a pregnant person did, though close ultrasound monitoring helps catch early signs.
Genetic influences
Genetics do not seem to be a main cause of Twin-to-twin transfusion syndrome. Current evidence suggests Twin-to-twin transfusion syndrome is driven mostly by how the shared placenta develops, and inherited genetic variations appear to play only a limited role.
Diagnosis
Twin-to-twin transfusion syndrome is usually diagnosed during pregnancy with ultrasound. Doctors look for changes in amniotic fluid around each twin, differences in bladder filling, and sometimes abnormal blood flow on Doppler ultrasound.
Treatment and drugs
Twin-to-twin transfusion syndrome needs urgent care from a fetal medicine team. Treatment may include laser surgery to seal shared placental vessels or draining extra amniotic fluid. Close ultrasound monitoring guides timing of delivery.
Symptoms
In Twin-to-twin transfusion syndrome, some pregnant people notice changes caused by a sudden buildup of fluid during pregnancy. The belly may seem to grow very quickly and feel tighter or more uncomfortable over a short time. Many cases are first picked up on ultrasound rather than by symptoms alone. Symptoms vary from person to person and can change over time.
Many people with Twin-to-twin transfusion syndrome feel well at first, and the condition is often found during a routine scan. Some of the early symptoms of Twin-to-twin transfusion syndrome can be easy to miss.
A fast increase in belly size over days, rather than weeks, can happen when extra fluid builds up around one twin. You might notice clothes fitting tighter or your abdomen seeming suddenly much larger.
The uterus can feel stretched, firm, or uncomfortable because of the extra fluid. Day to day, it can feel like constant pressure that does not ease much with rest.
Pressure from a very enlarged uterus can make it harder to take a full breath, especially when walking or lying flat. Some people also feel unusually full after eating only a small amount.
How people usually first notice Twin-to-twin transfusion syndrome?
Twin-to-twin transfusion syndrome is often not something a pregnant person can feel at first; it is usually first noticed during a routine ultrasound in a pregnancy with identical twins sharing one placenta, when one baby appears to have too much amniotic fluid and the other too little. When symptoms do show up, many people first notice a belly that seems to grow very quickly, a feeling of tightness or pressure, sudden weight gain, contractions, or shortness of breath from extra fluid building up around one twin. Because these early signs can overlap with other pregnancy changes, the clearest first signs of twin-to-twin transfusion syndrome usually come from ultrasound and close monitoring by a maternal-fetal medicine specialist.
Types of Twin-to-twin transfusion syndrome
Twin-to-twin transfusion syndrome does not have widely accepted disease variants in the way some inherited conditions do. Instead, doctors usually describe how severe it is and how it changes over time, most often with a staging system used during pregnancy. Symptoms don’t always look the same for everyone, and what shows up can depend on how uneven the blood flow is between the twins. If you are looking for the types of twin-to-twin transfusion syndrome, it is more accurate to think in terms of stages rather than true subtypes.
Can I slow down the onset of symptoms?
Usually, no—there is no proven diet, activity change, bed rest, or supplement that can meaningfully delay the start of twin-to-twin transfusion syndrome, because it happens when identical twins share one placenta and blood flow between them becomes uneven. What does help is early and regular ultrasound checks, since well-established care for twins sharing one placenta is close monitoring and, if TTTS appears, quick referral to a high-risk pregnancy specialist for treatment such as laser therapy. This cannot guarantee prevention, but finding problems early can improve the chance of timely treatment and better outcomes.
What genetics can tell you about symptoms
For twin-to-twin transfusion syndrome, genetics usually does not tell doctors much about which symptoms will appear, how severe they will be, or when they will start, because this condition is mainly caused by shared placental blood vessel connections in identical twins rather than an inherited gene change. In day-to-day terms, the main differences in symptoms, such as one twin growing poorly while the other develops too much fluid, are mostly linked to how blood flows through the placenta, not to the babies' DNA. Genetic testing may still be used in some pregnancies to look for other conditions that could affect one or both twins, but it does not usually explain or predict the course of twin-to-twin transfusion syndrome itself.
Causes and risk factors
The main cause of twin-to-twin transfusion syndrome is an uneven flow of blood through blood vessel connections in a shared placenta. The biggest risk is a pregnancy where identical twins share one placenta, and it can also affect some triplet or other multiple pregnancies with a shared placenta. There is no good evidence that twin-to-twin transfusion syndrome is caused by diet, exercise, stress, or an inherited gene change. Not everyone with the same risk develops the condition. So the risk is mostly biological and not something a parent did wrong.
What are the most common causes or risk factors?
The main cause of twin-to-twin transfusion syndrome is a shared placenta in identical twins, where blood vessels connect in a way that lets blood flow unevenly from one baby to the other. This means the biggest risk factor is being pregnant with identical twins who share one placenta; it does not happen in twins with separate placentas. It is not usually linked to genes, family history, diet, activity, or anything the pregnant person did.
Environmental and biological risk factors
Twin-to-twin transfusion syndrome happens only in a narrow set of pregnancies, so the risk factors are quite specific. Doctors often group risks into internal (biological) and external (environmental). For TTTS, the main risks come from how the pregnancy and placenta develop, and there are no well-established everyday environmental exposures known to directly cause it. Knowing the main risk factors for twin-to-twin transfusion syndrome can make the extra scans in these pregnancies feel more understandable.
Twin-to-twin transfusion syndrome can only develop when the babies share one placenta, called a monochorionic pregnancy. If each baby has a separate placenta, TTTS does not occur. Not every shared-placenta pregnancy develops TTTS, but this is the essential starting risk.
Risk is higher when the blood vessel connections between the babies inside the placenta are uneven. These links can let blood move more in one direction than the other. This pattern forms early in pregnancy and is not caused by routine daily activities.
When one baby has a smaller share of the placenta, the blood supply can be more vulnerable to imbalance. If that smaller share also has fewer or less balanced vessel connections, TTTS becomes more likely. The exact placental layout matters a great deal.
TTTS can also happen in triplet or higher-order pregnancies if at least two babies share one placenta. The same biological issue applies, with linked circulation inside the shared placenta. This is less common than in twins, but it is a recognized risk setting.
Genetic risk factors
For families expecting identical twins, one of the biggest questions is who is at risk for twin-to-twin transfusion syndrome. The main risk is a pregnancy where twins share one placenta, because that setup can allow blood to move unevenly between them. No specific inherited gene change has been proved to cause twin-to-twin transfusion syndrome, and it usually does not run in families. Awareness of risks can be empowering, since the key clue is the type of twin pregnancy rather than anything a parent passed on.
Shared placenta: Twin-to-twin transfusion syndrome occurs almost only in twins that share a single placenta, called a monochorionic pregnancy. This shared circulation creates the setting that makes unequal blood flow possible.
Placental vessels: The direct cause is an imbalance in the blood vessel connections inside the shared placenta. Over time, one twin may send more blood to the other than it gets back.
Identical twins: These pregnancies usually start when one fertilized egg splits into two babies, creating identical twins. The split is usually a chance early developmental event, not a proven inherited trait.
Family history: Family history is not a well-established risk factor for twin-to-twin transfusion syndrome. Most cases happen without a known pattern passed through generations.
Inherited changes: No single gene change or chromosome problem has been confirmed as a common cause of twin-to-twin transfusion syndrome. In most families, genetic testing does not identify a reason for the condition.
Lifestyle risk factors
Twin-to-twin transfusion syndrome is not caused by a pregnant person's lifestyle, but daily habits can still influence symptom burden, hydration, fetal growth support, and how quickly warning signs are recognized. In practice, how lifestyle affects twin-to-twin transfusion syndrome is mostly through supporting the pregnancy and reducing delays in care rather than preventing the condition itself. The most important issues are avoiding substances that reduce placental and fetal health, maintaining adequate nutrition and fluids, and matching activity to medical advice.
Smoking, vaping nicotine, and other tobacco exposure do not cause twin-to-twin transfusion syndrome, but they can reduce oxygen delivery and impair placental function in an already high-risk twin pregnancy. This may worsen fetal growth concerns and increase the chance of complications.
Alcohol and non-prescribed drugs do not trigger twin-to-twin transfusion syndrome, but they can add fetal injury and maternal health risks on top of the condition. Avoiding these substances helps reduce preventable harm while the pregnancy is being closely monitored.
Poor intake does not cause twin-to-twin transfusion syndrome, but inadequate calories, protein, iron, and other nutrients can make it harder to support maternal health and twin growth. Following the obstetric team's nutrition advice may help with energy, anemia risk, and overall pregnancy resilience.
Dehydration does not create twin-to-twin transfusion syndrome, but poor fluid intake can worsen maternal dizziness, fatigue, and overall tolerance of pregnancy symptoms. Steady hydration is often encouraged because it supports circulation and general well-being during intensive monitoring.
Risk prevention
For families expecting twins, the most important point is that twin-to-twin transfusion syndrome usually cannot be fully prevented once identical twins share a placenta. In practice, prevention means lowering the chance of serious complications through early recognition, close monitoring, and timely treatment if TTTS develops. Prevention is about lowering risk, not eliminating it completely. This matters because early symptoms of twin-to-twin transfusion syndrome can be subtle at first, while the pregnancy may still feel mostly normal day to day.
Start prenatal care early and confirm whether the twins share one placenta, because TTTS occurs in these pregnancies. An early scan helps identify who needs closer follow-up from the start.
Regular ultrasound checks are the main way to reduce harm from twin-to-twin transfusion syndrome. In pregnancies at risk, scans are often done every 2 weeks from about 16 weeks onward so fluid levels, bladder filling, and growth can be watched closely.
Care from a maternal-fetal medicine specialist can improve the chances that TTTS is caught and treated promptly. These teams can also decide when procedures such as laser treatment or amnioreduction may be needed.
Between visits, contact your care team quickly if you notice sudden belly growth, tightness, contractions, shortness of breath, or a rapid jump in weight from fluid buildup. These signs do not always mean TTTS, but they can signal that the pregnancy needs urgent review.
Can you prevent Twin-to-twin transfusion syndrome?
Twin-to-twin transfusion syndrome usually cannot be prevented, because it happens when identical twins share one placenta and the blood flow between them develops unevenly early in pregnancy. It is not caused by anything a parent did or did not do. What can help is early and regular prenatal care, with frequent ultrasound checks in pregnancies where twins share a placenta, so problems can be found quickly and treated if needed.
Transmission
Twin-to-twin transfusion syndrome is not infectious, so it cannot spread from one pregnant person to another, between family members, or through touch, air, food, or sex. It develops only in some pregnancies where identical twins share one placenta and there are unbalanced blood vessel connections between the twins.
If you are wondering how twin-to-twin transfusion syndrome is inherited, it usually is not inherited and is not thought to be passed down in families in the way many genetic conditions are. For many living with a twin pregnancy, this means twin-to-twin transfusion syndrome is considered a pregnancy-related complication rather than something contagious or something a parent caused.
When to test your genes
Gene testing is not used to detect or manage twin-to-twin transfusion syndrome. Early detection depends on frequent ultrasound and Doppler monitoring in pregnancies where twins share one placenta, often starting around 16 weeks. If TTTS is suspected, care is customized through fetal medicine, not DNA results.
Diagnosis
Twin-to-twin transfusion syndrome is usually found during pregnancy, often when routine ultrasound scans show that identical twins sharing one placenta are not growing or handling fluid in the same way. For many, the first step comes when everyday activities start feeling harder, such as rapid belly growth, tightening, or shortness of breath from extra amniotic fluid. The diagnosis of twin-to-twin transfusion syndrome is based mainly on ultrasound findings, with other fetal tests helping confirm how serious it is.
Doctors usually begin with an ultrasound to check whether the twins share one placenta and to compare their growth, movement, and amniotic fluid levels. A large fluid pocket around one twin and very low fluid around the other is a key sign of twin-to-twin transfusion syndrome.
The scan also looks at each twin’s bladder, because the donor twin may have a very small or hard-to-see bladder while the recipient twin’s bladder may look larger. These patterns can support the diagnosis when fluid differences are already present.
Doppler ultrasound measures blood flow in important fetal blood vessels, including the umbilical cord and heart-related vessels. Abnormal flow can show how much strain the syndrome is causing and helps doctors judge severity.
Repeated measurements are used to see whether one twin is much smaller than the other or growing more slowly over time. Growth difference alone does not confirm TTTS, but it can add important clues.
How is Twin-to-twin transfusion syndrome diagnosed?
Twin-to-twin transfusion syndrome is usually diagnosed during pregnancy with repeated ultrasound scans in twins who share one placenta, because the scans can show that one baby has too little fluid around them while the other has too much. Doctors also look at how full each baby's bladder is, how well they are growing, and how blood is moving through the umbilical cord and heart to judge how severe it is. Genetic testing is not used to diagnose this condition.
Stages of Twin-to-twin transfusion syndrome
Twin-to-twin transfusion syndrome has recognized progression stages, most often described with the Quintero staging system during pregnancy. These stages are based on ultrasound findings that show how the shared placenta is affecting blood flow between identical twins who share one placenta. In day-to-day terms, the condition can move from fluid imbalance between the babies to signs that one or both babies are under serious strain. Early and accurate diagnosis helps you plan ahead with confidence.
Stage I
One twin has too much amniotic fluid and the other has too little, but the smaller twin’s bladder can still be seen filling on ultrasound. This is often the earliest point in the stages of twin-to-twin transfusion syndrome. Some pregnancies stay stable for a time, while others worsen.
Stage II
The fluid difference is still present, and the smaller twin’s bladder is no longer seen on ultrasound during the scan. This suggests that reduced blood flow is affecting urine production. The process can involve several steps, each one adding to the picture.
Stage III
Blood flow changes now appear in one or both twins on Doppler ultrasound, which looks at circulation in important blood vessels. This means the condition is putting more stress on the babies’ hearts and blood flow. Treatment is usually considered urgent at this stage.
Stage IV
One or both twins develop hydrops, which means abnormal fluid builds up in the body, such as around the lungs, heart, or under the skin. This is a sign of severe strain and a high risk of complications. Close specialist care is needed right away.
Stage V
One twin dies in the womb. This is the most severe stage and can also put the surviving twin at risk. Care then focuses on the health of the remaining twin and the pregnant parent.
Outlook and prognosis
The outlook for twin-to-twin transfusion syndrome depends mainly on how early it is diagnosed, how severe it is, and whether treatment such as fetoscopic laser therapy is available. Without treatment, severe cases carry a very high risk of losing one or both twins, while modern treatment has greatly improved survival. After laser therapy, at least one twin survives in most pregnancies, and both twins survive in a substantial proportion, although exact rates vary by stage and treatment center. Even when the babies survive, there remains a risk of complications related to prematurity, growth problems, and brain injury, so long-term neurodevelopmental follow-up is often needed. Maternal mortality from twin-to-twin transfusion syndrome is extremely rare, but the pregnancy can be emotionally and medically high risk and requires close specialist care. Overall, prognosis is best when the condition is detected promptly through regular monitoring of monochorionic twin pregnancies and treated in an experienced fetal medicine center.
Long-term effects
For families affected by twin-to-twin transfusion syndrome, the long-term picture often depends on how severe it was, when it was treated, and how early the babies were born. Some children do very well after birth, while others may have lasting health or developmental challenges linked to reduced blood flow, heart strain, or prematurity. Long-term effects vary widely, and they can differ between the donor twin and the recipient twin. In follow-up visits, doctors may watch for growth, brain and nerve development, heart health, and early symptoms of twin-to-twin transfusion syndrome-related complications.
Some children may have delays in movement, speech, learning, or behavior as they grow. This can be mild and improve with time, or it can be more lasting if the brain was affected before birth or by very early delivery.
A small number of survivors develop lasting movement and muscle control problems, including cerebral palsy. The risk is higher when twin-to-twin transfusion syndrome was severe or when there were major complications before or around birth.
The donor twin may stay smaller for a time, and some children have ongoing differences in weight or height during childhood. In many living with twin-to-twin transfusion syndrome, growth catches up partly or fully, but this is not the same for every child.
The recipient twin can have lingering heart changes because the heart had to work harder before birth. Most improve after delivery, but some children need longer follow-up for heart size, pumping strength, or valve function.
How is it to live with Twin-to-twin transfusion syndrome?
Living with twin-to-twin transfusion syndrome can turn a pregnancy from joyful to intensely watchful, because care often shifts quickly to frequent ultrasounds, specialist visits, and hard decisions made on a tight timeline. For many carrying twins with TTTS, daily life becomes a balance of physical symptoms, emotional strain, travel to fetal medicine centers, and uncertainty about preterm birth or procedures such as laser treatment. The effects reach well beyond the pregnant person: partners, family, and other children may need to adjust schedules, share caregiving, and carry the emotional weight too. Even so, close monitoring and modern fetal therapy have improved outcomes, and many families find that clear information and strong support make this demanding period more manageable.
Treatment and drugs
Twin-to-twin transfusion syndrome is treated during pregnancy based on how severe it is, how far along the pregnancy is, and how the twins are doing on ultrasound. Mild cases may be watched very closely with frequent scans, while more serious twin-to-twin transfusion syndrome often needs a procedure to remove extra amniotic fluid or, more commonly, laser treatment that seals the shared blood vessels causing the problem. There is no medicine that cures twin-to-twin transfusion syndrome itself, but drugs may still be used to support the pregnancy, such as steroids to help the babies’ lungs mature if early delivery is likely. Not every treatment works the same way for every person, and in some pregnancies the safest plan is careful monitoring followed by delivery at the right time. Because early symptoms of twin-to-twin transfusion syndrome are usually seen on ultrasound rather than felt day to day, care is usually led by a maternal-fetal medicine specialist with close follow-up.
Can you cure Twin-to-twin transfusion syndrome?
Twin-to-twin transfusion syndrome does not have a simple guaranteed cure, but doctors can sometimes treat the cause during pregnancy, most often with a laser procedure that closes the shared blood vessels causing the uneven blood flow. Close monitoring, removing extra fluid around one baby, and sometimes early delivery can also help lower risks and improve the babies' chances.
Non-drug treatment
Twin-to-twin transfusion syndrome can turn a pregnancy into a cycle of frequent scans, difficult decisions, and careful planning for both babies. Non-drug treatments focus on watching blood flow and amniotic fluid closely, treating the abnormal vessel connections in the placenta when needed, and timing delivery as safely as possible. Not every approach works the same way, because treatment depends on how severe the syndrome is, how far along the pregnancy is, and how each twin is doing.
Frequent ultrasound checks are a core part of care for twin-to-twin transfusion syndrome. These visits track growth, bladder filling, blood flow, and amniotic fluid so the team can spot early symptoms of twin-to-twin transfusion syndrome and act quickly if the condition worsens.
Fetoscopic laser treatment is often the main procedure for more severe cases before the babies are mature enough for delivery. A specialist places a small camera into the womb and seals the shared placental blood vessels that are causing the uneven blood flow.
Removing extra amniotic fluid from around the recipient twin can help relieve pressure in the womb and may ease symptoms for the pregnant parent, such as tightness or shortness of breath. It does not fix the placental vessel problem, but it may be used when laser treatment is not possible or as a temporary step.
Some pregnancies, especially milder stage I cases, may be managed with close follow-up instead of an immediate procedure. This means repeated scans and specialist review so treatment can be started if either twin begins to show signs of strain.
Your genes may have an impact on how drugs work for you
For twin-to-twin transfusion syndrome, treatment is usually guided by the babies’ blood flow and fluid levels on ultrasound, not by inherited gene differences. Medicines that may be used around treatment, such as steroids to help the babies’ lungs mature early or medicine to relax the uterus and calm contractions, can affect people a little differently, but this is not usually something doctors predict with genetic testing in this condition. In other words, genes are not known to play a major, routine role in choosing medicines for twin-to-twin transfusion syndrome at this time.
Pharmacological treatments
Twin-to-twin transfusion syndrome is not usually treated with medicine alone, because the main problem is abnormal blood flow between identical twins sharing a placenta. The most effective treatment is usually a procedure rather than a drug, but a few medicines may be used in specific situations to support the pregnancy or prepare for early delivery. Sometimes medicines are taken short-term (acute treatment), while others are used long-term (maintenance therapy). For many families asking about treatment for twin-to-twin transfusion syndrome, it helps to know that drugs play a supporting role, not the central one.
There is no medicine that can correct the shared placental blood-vessel problem that causes twin-to-twin transfusion syndrome. In most cases, treatment centers on close monitoring and procedures such as fetoscopic laser therapy rather than a drug.
Betamethasone or dexamethasone may be given if there is a high chance of preterm birth. These medicines help the babies’ lungs mature faster and are often used when early symptoms of twin-to-twin transfusion syndrome lead to urgent delivery planning.
Magnesium sulfate may be used shortly before very early preterm delivery to help protect the babies’ brains. It is not a treatment for the transfusion itself, but it can lower the risk of certain complications of extreme prematurity.
Nifedipine is sometimes used around fetoscopic laser treatment to relax the uterus and reduce contractions. Some specialist centers also use it to lessen strain on the recipient twin’s heart before or after the procedure.
Genetic influences
When twin-to-twin transfusion syndrome happens in a pregnancy, many families immediately wonder whether it was inherited. It’s natural to ask whether family history plays a role. In most cases, twin-to-twin transfusion syndrome is not caused by a gene change passed down from a parent; it develops because identical twins share one placenta and the blood vessel connections inside that placenta form in an unbalanced way. That means the main answer to what causes twin-to-twin transfusion syndrome is usually a placental problem, not an inherited disorder. For most people, this also means the chance of it happening again is low, because the kind of twin pregnancy linked to twin-to-twin transfusion syndrome usually occurs by chance rather than running strongly in families.
Is Twin-to-twin transfusion syndrome genetic?
Genetics do not seem to be a main cause of Twin-to-twin transfusion syndrome. Current evidence suggests Twin-to-twin transfusion syndrome is driven mostly by how the shared placenta develops, and inherited genetic variations appear to play only a limited role.
Having a genetic risk is not necessarily a diagnosis
Genetic variants are a usual part of being human and are widely found in the general population. Most do not directly affect health and simply reflect normal human diversity. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, especially when several genes and environmental factors play a role. In some cases, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
Many families ask whether genetic testing changes treatment for twin-to-twin transfusion syndrome. In most pregnancies, treatment is guided mainly by ultrasound findings, how far along the pregnancy is, and how severe the blood-flow and fluid changes are, because twin-to-twin transfusion syndrome is usually caused by abnormal blood vessel connections in a shared placenta rather than an inherited genetic condition. Genetics is only one factor, and testing is more often considered when scans show birth defects, unusual growth patterns, or other signs that suggest something besides twin-to-twin transfusion syndrome may also be going on. That information can help the care team explain options and plan procedures such as laser treatment of the placental vessels, or decide whether a different approach is needed. Medicines used around treatment, including anesthesia, pain relief, antibiotics, steroid shots if early delivery seems likely, or drugs to calm contractions, are usually chosen based on the pregnant person’s health and the stage of pregnancy, not on routine genetic testing. Still, if there is a known family history of unusual drug reactions or past problems with anesthesia, sharing that with the medical team can help them choose medicines more safely.
Interactions with other conditions
For families dealing with twin-to-twin transfusion syndrome, the biggest concern is often how it can add to other problems in a shared-placenta twin pregnancy rather than acting as a completely separate issue. It may occur alongside growth restriction in one or both twins, extra strain on the heart of the twin receiving too much blood, and too little amniotic fluid around the donor twin while the recipient twin has too much, which can raise the risk of preterm labor. Doctors call it a “comorbidity” when two conditions occur together, and in Twin-to-twin transfusion syndrome this matters because heart failure, abnormal blood flow, or severe prematurity can worsen the overall outlook. Some pregnancies also have overlap with a related condition called twin anemia-polycythemia sequence, where one twin becomes anemic and the other has thicker, more concentrated blood. Because the early symptoms of Twin-to-twin transfusion syndrome can resemble other complications of monochorionic twin pregnancy, specialists usually monitor closely with ultrasound and heart checks to sort out what is happening. Care is often coordinated through maternal-fetal medicine and newborn specialists, since the effects of Twin-to-twin transfusion syndrome can continue after birth if one or both babies are born early or need treatment for circulation or breathing problems.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Twin-to-twin transfusion syndrome?
Twin-to-twin transfusion syndrome can look like other problems in identical twins who share a placenta, especially when one baby is much smaller than the other because it gets less of the placenta, or when there is a blood-count imbalance between the twins without the big fluid changes seen in TTTS. Doctors may also consider causes of too much or too little fluid around one baby, such as certain birth defects or other placenta problems, because these can create a similar picture on ultrasound.
History
Long before modern pregnancy scans, doctors and midwives noticed that some identical twin pregnancies developed very differently. One baby might seem to grow well while the other struggled, and sometimes both babies became seriously unwell before birth. These puzzling patterns are now understood as twin-to-twin transfusion syndrome, a condition that affects some twins who share a placenta.
At first, these pregnancies were described only after delivery or after a pregnancy loss, because there was no reliable way to see what was happening inside the womb. In recent decades, awareness has grown as ultrasound made it possible to watch shared-placenta twin pregnancies more closely during pregnancy, rather than piecing the story together afterward. Doctors began to recognize a clearer pattern: blood flow through shared placental vessels could become unbalanced, leaving one twin with too little blood and fluid and the other with too much.
That change in understanding mattered in real life. Instead of families hearing only that one twin was smaller or that there was “too much fluid,” specialists could identify early symptoms of twin-to-twin transfusion syndrome and follow the pregnancy more carefully. Over time, doctors also developed staging systems to describe how severe the condition appeared on ultrasound, which helped guide treatment and timing.
Treatment changed the history of twin-to-twin transfusion syndrome even more. Earlier care was mostly supportive, with close monitoring and, in some cases, procedures to reduce excess amniotic fluid. As fetal medicine advanced, surgeons developed laser treatment to seal the abnormal blood vessel connections on the placenta, aiming to treat the cause rather than only the effects. This approach, together with better imaging and specialized fetal care centers, has improved outcomes for many families.
The history of twin-to-twin transfusion syndrome is really a story of seeing more clearly. What was once a confusing and often devastating complication became something doctors could diagnose earlier, describe more accurately, and in many cases treat before birth. Even so, the condition can still be serious, which is why careful monitoring in a specialist center remains such an important part of care.